Theodore A. Omachi

Statistics

Publications

Citations

4.3K

H-Index

Active since

2007

Affiliations

University of California, San Francisco(Current)

Kaiser Permanente

University of California System

Roche (United Kingdom)

University of South Florida

Theodore A. Omachi is an author at University of California, San Francisco specializing in medicine, chronic obstructive pulmonary disease, and obstructive lung disease.

ORCID

Publications per year

2007–2025

Publications

Efficacy and safety of omalizumab in nasal polyposis: 2 randomized phase 3 trials

Philippe Gevaert, Theodore A. Omachi, Jonathan Corren et al. · Journal of Allergy and Clinical Immunology · 2020 · 697 citations · Full text

Medicine, Otolaryngology, Pharmacotherapy +17

Efficacy and safety of lebrikizumab (an anti-IL-13 monoclonal antibody) in adults with moderate-to-severe atopic dermatitis inadequately controlled by topical corticosteroids: A randomized, placebo-controlled phase II trial (TREBLE)

Eric L. Simpson, Carsten Flohr, Lawrence F. Eichenfield et al. · Journal of the American Academy of Dermatology · 2018 · 329 citations · Full text

Medicine, Dermatology, Immunology +17

Influence of anxiety on health outcomes in COPD

Mark D. Eisner, Paul D. Blanc, Ed Yelin et al. · Thorax · 2010 · 285 citations · Full text

Medicine, Psychology, Health Psychology +15

Socioeconomic status, race and COPD health outcomes

Mark D. Eisner, Paul D. Blanc, Theodore A. Omachi et al. · Journal of Epidemiology & Community Health · 2009 · 268 citations · Full text

Public Health, Population Health Sciences, Epidemiologic Methods +16

A randomized multicenter study evaluating Xolair persistence of response after long-term therapy

Dennis K. Ledford, William W. Busse, Benjamin Trzaskoma et al. · Journal of Allergy and Clinical Immunology · 2016 · 222 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +14

1–5 of 42